Упрощенная HTML-версия
459.
Tuck M. L. Obesity, the sympathetic nervous system, and essential
hypertension / M. L. Tuck // Hypertension. – 1992. – Vol. 19 (suppl. I). – P.
167-177.
460.
Tune J. D. Effects of leptin on cardiovascular physiology / J. D. Tune, R. V.
Considine // J. Am. Soc. Hypertens. – 2007. – Vol. 1, № 4. – P. 231 – 241.
461.
Use of moxonidine as initial therapy and in combination in the treatment of
essential hypertension – results of the TOPIC Study / J. Waters [et al.] // J.
Clinical Basic Cardiol. – 1999. – Vol. 2. – P. 219-224.
462.
Use of moxonidine in elderly patients with resistant hypertension / U. Martin
[et al.] // J. Clin. Pharm. Ther. – 2005. – Vol. 30, № 5. – P. 433-437.
463.
van Zwieten P.A. Centrally acting imidazoline II-receptor agonists: do they
have a place in the management of hypertension / P.A. van Zwieten // Am. J.
Cardiovasc. Drugs . – 2001. – Vol. 1, № 5. – P. 321-326.
464.
Verdecchia P. Prognostic value of ambulatory blood pressure. Current
evidence and clinical implications / P. Verdecchia // Hypertension. – 2000. –
Vol. 35. – Р. 844-851.
465.
von Willebrand factor and endothelial damage in essential hypertension / A. D.
Blann [et al.] // J. Hum. Hypertens. – 1993. – Vol. 7. – P. 107–111.
466.
Vrijkotte T. G. M. Effects of Work Stress on Ambulatory Blood Pressure,
Heart Rate Variability / T. G. M. Vrijkotte, L. J. P. van Doornen, E. J. C. de
Geus // Hypertension. – 2000. – № 35. – P. 880-886.
467.
Wang L. Triglyceride-rich lipoprotein lipolysis increases aggregation of
endothelial cell membrane microdomains and produces reactive oxygen
species / L. Wang [et al.] // Am. J. Physiol. Heart. Circ. Physiol. – 2008. – Vol.
295, № 1. – P. 237–244.
468.
Weight change and blood coagulability and fibrinolysis in healthy obese
women / P. Rissanen [et al.] // Int. J. Obes. – 2001. – Vol. 25. – P. 212–218.
469.
Weight reduction and pharmacologic treatment in obese hypertensives / K.
Masuo [et al.] // Am. J. Hypertens. – 2001. – Vol. 14. – P. 530–538.